NCI Standard Funding Opportunity Announcements
|
Current and Recent
Program Announcements |
Current and Recent
Requests for Applications |
Current
and Recent NCI and Trans-NIH Initiatives |
Requests for Proposals
|
Standard Due Dates
|
|
Ongoing |
All Ranks |
Non-federal |
Culture of Health |
Robert Wood Johnson Foundation (RWJF)
Evidence for Action: Investigator-Initiated Research to
Build a Culture of Health
Development of data and evidence needed to advance a Culture of Health.
Research could: (1) Provide evidence for factors in the Action
Framework that are believed - but not yet proven to impact health;
(2) Reframe or challenge existing ideas; (3) Integrate existing
data and methods across disciplines and sectors; and/or (4)
Identify actions that can improve health for marginalized
populations.
Due Dates: |
Applicants can expect
notification w/in 6-8 weeks of a 2-page Letter of Intent submission.
Invited applicants will have 2 months to submit a proposal notified.
Funding decisions will generally be made within 6-8 weeks of the full
submission. |
Amount & Project Period: |
~$200,000 - up to 30 months |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Links: |
Overview Ι
2015 Call For Proposals |
|
|
Ongoing |
All Ranks |
Federal |
See BAA |
Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research
The purpose of this BAA is to solicit research proposals in the
engineering, physical, life, and information sciences for
submission to the Army Research Office (ARO) for consideration
for possible funding.
Due Dates: |
Open until Mar. 31, 2017
Proposers are to submit white papers prior to submission of a
complete proposal. Based on assessment of white papers, feedback will be
provided to encourage or discourage submission of full proposals. |
Amount & Project Period: |
No specific dollars have been reserved - 3
years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Links: |
ARO CORE
BAA-W911NF-12-R-0012-Mod 03
|
|
|
Ongoing |
All Ranks |
Federal |
See BAA |
United States Army Medical Research and Materiel
Command (USAMRMC)Broad Agency Announcement for Extramural
Medical Research
W81XWH-16-R-BAA1
The mission of the USAMRMC is to provide solutions to medical
problems of importance. Projects must be for basic and applied
research. Projects must be for scientific study and
experimentation directed toward advancing the state of the art
or increasing knowledge or understanding. (See general
description of research and development programs, including
research areas of interest in the announcement.)
Due Dates: |
Open continuously from Oct. 01, 2015 through
Sept. 30, 2016. Organizations are required to submit
pre-proposals/pre-applications. |
Amount & Project Period: |
Budgets are not limited - up to 5 years |
Eligibility: |
All individuals, regardless of ethnicity,
nationality, or citizenship status, employed by, or affiliated with, an
eligible organization |
Contact: |
Linda
Nolan (x6071) |
Link: |
W81XWH-16-R-BAA1 |
|
|
Ongoing |
All Ranks |
Non-federal |
Macroglobulinemia |
International Waldenstrom's Macroglobulinemia Foundation
Research Grants
To further scientific knowledge of the cause, diagnosis,
treatment, or cure for the disease Waldenstrom's
Macroglobulinemia, a type of non-Hodgkin's Lymphoma also called
lymphoplasmacytic lymphoma.
Due Dates: |
Ongoing |
Amount & Project Period: |
$50,000 to $100,000 - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Link: |
Guidelines
|
|
NEW |
January 04 |
All Faculty |
Non-federal |
Afatinib Studies |
NCCN Afatinib Combination Research Grant
Opportunity
To support NCCN investigator initiated studies
for the performance of preclinical, clinical,
and correlative studies of afatinib containing
combinations in the treatment of lung and head
and neck cancers. The motivation behind this
RFP is to facilitate development of combination
therapies using afatinib. Towards this goal,
several specific additional therapies may be
available from collaborating pharmaceutical
companies, and are detailed in the
RFP, though investigations addressing any
combination regimens will be considered.
Due Dates: |
Dec. 31 (OSR) Ι Jan. 04 (Sponsor)
Proposals are required to be submitted electronically to the NCCN
research portal at
https://www.mednetstudy.com/sgs/nccn/. |
Amount & Project Period: |
Funding should not exceed $600,000 (TOTAL).
Clinical study maximum $300,000 + correlative study maximum $200,000 +
multi-institutional funding maximum $100,000 = $600,000 MAXIMUM funding. |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
Links: |
RFP
|
NCCN Oncology Research Program (ORP) |
|
|
January 07 |
Postdocs |
Non-federal |
Career Development |
American Brain Tumor Association
Basic
Research Fellowship Program
Applicants should
be on-track to pursue a career in brain tumor
research with a sponsor who has a demonstrated
history of brain tumor research and mentorship.
Due Dates: |
Jan. 05 (OSR) Ι Jan. 07 (Sponsor) |
Amount & Project Period: |
$100,000 - 2 years ($45,000 in salary support
and $5,000 in researcher discretionary funds per annum.) |
Eligibility: |
MDs must be w/in 2 years of residency
completion (unless program mandates research studies earlier), or within
4 years of post-residency training as of July 1, 2015. PhDs must have
doctorate conferred by 01/01/2015 and be no more than 4 years
post-conferral of PhD by 07/01/2015. |
Contact: |
Linda
Nolan (x6071) |
Link: |
Basic Research Fellowship Program |
|
|
January 09 (LOI) |
All Ranks |
Federal |
Cancer Detection |
Cancer Detection, Diagnosis, and Treatment
Technologies for Global Health
Supports development of cancer-relevant
technologies suitable for use in low- and
middle-income countries (LMICs). Specifically
seeking
projects to adapt, apply, and validate existing
or emerging technologies into a new generation
of user-friendly, low-cost technologies for
imaging, detecting, diagnosing, preventing,
and/or treating cancers in humans living in
LMICs.
Due Dates: |
Jan. 09 (Letter of Intent)
Applications due: Feb. 07 (OSR) Ι Feb. 09 (Sponsor) |
Amount & Project Period: |
$325,000/yr. (Direct Costs) for
UG3 phase - 2 years max. $650,000/yr. (Direct Costs) for UH3 phase - 3
years max. |
Eligibility: |
All Ranks |
Contact: |
Linda Nolan (x6071) |
RFA Link: |
RFA-CA-15-024 |
|
NEW |
January 09 (LOI) |
Research Scientists |
Federal |
Career Development |
NCI Research Specialist Award
Designed to encourage development
of research career opportunities for exceptional
scientists who want to pursue research within
the context of an existing cancer research
program, but not serve as independent
investigators.
Due Dates: |
Feb. 07 (OSR) Ι Feb. 09 (Sponsor) |
Amount & Project Period: |
Up to 100% salary support (not to exceed NIH Salary
Cap) commensurate w/level of effort on NCI-funded research grants, and
travel costs for research meetings/conferences up to $5,000/year. Awards
are for 5 years. |
Eligibility: |
The Research
Specialist:
Must have an advanced degree
(e.g. Masters, PhD, DVM, DDS or MD);
Must have full-time
appointment, and is required to commit a minimum of 50% of full-time
professional effort on NCI-funded research;
Should have demonstrated
professional accomplishments consonant w/his or her career status, and
should have demonstrated cancer research experience relevant to the NCI
mission; and
Is Intended for cancer
research-oriented investigators who have shown clear evidence of
productivity and research excellence in their field of training. |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-16-025 |
|
National Institute of Environmental Health Sciences and National
Cancer Institute
NEW |
January 10 (LOI) |
All Ranks |
Federal |
Breast Cancer & Environment |
Breast Cancer and the Environment
Communication Research Initiative
Supports research on behavioral uptake of risk messaging and individual
behavioral change. May also be utilized to
explore implementation of existing risk messages
and whether such messaging has affected policy
change or large scale systemic changes to reduce
the sources of pollution that pose a risk for
breast cancer.
Due Dates: |
Jan. 10 (Letter of Intent)
Applications due: Feb. 08 (OSR) Ι Feb. 10 (Sponsor) |
Amount & Project Period: |
$275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-ES-15-017 |
Companion RFA: |
RFA-ES-15-0-15 (R03) |
|
Common Fund initiative
Administered by NCI |
January 11 (LOI) |
All Ranks |
Federal |
Metabolomics |
Metabolomics Data Analysis
To foster collaboration between bioinformaticians, metabolomics experts,
and/or biomedical researchers in efforts to
improve the ability to analyze metabolomics data
to address biomedical questions.
Due Dates: |
Jan. 11 (Letter of Intent)
Applications due: Feb. 09 (OSR) Ι Feb. 11 (Sponsor) |
Amount & Project Period: |
$100,000 - 1 year |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-RM-15-021 |
|
NEW |
January 14 |
All Ranks |
Federal |
Genomic Technology |
Novel Genomic Technology Development
Initiative seeks to optimize innovation, insight
and cutting edge conceptual and technological
breakthroughs by catalyzing research that
emanates from the identified innovative
questions in symptom and genomic nursing
science. These innovative questions are
reflective of broad domains from which more
specific novel hypotheses or problems to be
solved can be derived.
|
NEW
NEW |
January 15 |
All Ranks |
Non-federal |
Gastrointestinal |
American Gastroenterological Association
Research Awards
AGA-Elsevier Pilot Research Award
Supports pilot research projects in gastroenterology-or
hepatology-related areas.
Due Dates: |
Jan. 13 (OSR) Ι Jan. 15
(Sponsor)
|
|
Amount & Project Period: |
$25,000 - 1 year |
Eligibility: |
All Ranks - must hold an MD, PhD or equivalent
degree and a fulltime faculty appointment.
AGA Membership is required. |
Contact: |
Linda
Nolan (x6071) |
Link: |
Guidelines |
AGA-Elsevier Gut Microbiome Pilot Research
Award
Opportunity offered to early stage and
established investigators to support pilot
research projects pertaining to the gut
microbiome.
Due Dates: |
Jan. 13 (OSR) Ι Jan. 15
(Sponsor)
|
|
Amount & Project Period: |
$25,000 - 1 year |
Eligibility: |
All Ranks - must hold an MD, PhD or equivalent
degree and a fulltime faculty appointment.
AGA Membership is required. |
Contact: |
Linda
Nolan (x6071) |
Link: |
Guidelines
|
|
NEW |
January 15 (3:00PM ET) |
Postdocs |
Non-federal |
Career Development |
Lymphatic Education & Research Network
Postdoctoral Fellowship Awards Program
Research areas of interest include lymphatic
vessel biology and pathology; physiological
mechanisms of normal and pathological
lymphangiogenesis; animal models of the
lymphatic system and its disorders; studies
(including lymphatic imaging) that address
regulation of lymphatic structure and function.
Due Dates: |
Jan. 13 (OSR) Ι Jan. 15 (Sponsor) |
Amount & Project Period: |
$87,396 - $98,304 - 2 years |
Eligibility: |
Must hold a PhD and/or MD or equivalent
degree and have completed <3
years of full-time postdoctoral research experience by July 1, 2016. |
Contact: |
Linda
Nolan (x6071) |
Links: |
Overview Ι
Postdoctoral Awards Program |
|
NEW |
January 15 (Noon, EST) |
Clinical Faculty |
Non-federal |
Pancreatic - Clinical Trials |
2016 Pancreatic Cancer Action Network -
Research
Acceleration Network (RAN) Grant
Funding for
research in pancreatic cancer that includes a
clinical project with an endpoint that improves
prevention, detection/diagnosis/ prognosis,
treatment or supportive care. Clinical component
must be implemented no later than beginning of
last year of grant term.
Due Dates: |
Jan. 13 (OSR) Ι Jan. 15 (Sponsor) (Noon, EST) |
Amount & Project Period: |
$1,000,000 (TOTAL) - 3 years |
Eligibility: |
One applicant, designated Contact PI, and at
least one co-Principal Investigator from two distinct institutions
required. |
Contact: |
Linda Nolan (x6071) |
Links: |
Guidelines and Application Instructions
proposalCENTRAL
(Submission site) |
|
NEW |
2016 Pancreatic Cancer Action Network -
Research Acceleration Network-2 (RAN-2)
Grant
Research in pancreatic cancer that includes a
Phase II treatment clinical trial or a robust
prevention, detection/diagnosis/prognosis or
supportive care trial implemented no later than
the beginning of 2nd year of grant term.
Due Dates: |
Jan. 13 (OSR) Ι Jan. 15 (Sponsor) (Noon, EST) |
Amount & Project Period: |
$2,000,000 (TOTAL) - 3 years |
Eligibility: |
One applicant, designated
Contact PI, and at least one co-PI from two distinct institutions
required |
Contact: |
Linda
Nolan (x6071) |
Links: |
Guidelines and Application Instructions
proposalCENTRAL
(Submission site) |
|
NEW |
January 15 |
See Below |
Non-federal |
Radiologic Science |
Research & Education Foundation of the
Radiological Society of North America (RSNA)
Due Dates: |
Jan. 13 (OSR) Ι Jan. 15
(Sponsor) |
Contact: |
Linda
Nolan (x6071) |
Research Resident/Fellow Grant
Provides trainees not yet professionally established in the radiologic
sciences an opportunity to gain further insight
into scientific investigation and to develop
competence in research techniques and methods.
Amount & Project Period: |
$30,000 for a 1-year Research Resident project
or
$50,000 for a 1-year Research Fellow project. |
Eligibility: |
Minimum of 50% effort on approved research
project.
RSNA Member (at any level)
at the time of application.
Resident Grant: Must have completed
internship year (PGY-1) and at least 6-months of specialty training in
the radiologic sciences (PGY-2).
Fellow Grant: Must be in last year of,
or have completed, prescribed residency training. If awarded, recipient
must be in a fellowship position during period of grant support.
See
Details for addnl. Criteria. |
Links: |
Funding Opportunities Ι
Details/Application |
|
NEW |
Research Scholar Award
Supports junior faculty members who have
completed the conventional resident/fellowship
training programs but have not yet been
recognized as independent investigators.
Amount & Project Period: |
$75,000/yr. - 2 years (Intended to secure
protected time for recipient; may not be used for non-personnel research
expenses.) |
Eligibility: |
Junior faculty w/in 5 years of initial faculty
appt. w/academic rank of instructor or assistant professor, (or
equivalent) in department of radiology, radiation oncology, or nuclear
medicine.
Must be RSNA member.
Requires 40% effort.
See details for addnl. Criteria. |
Links: |
Funding Opportunities Ι
Details-Application |
|
NEW |
Research Seed Grant
Enables investigators to gain experience in defining objectives and
testing hypotheses in preparation for major
grant applications to corporations, foundations
and governmental agencies
Amount & Project Period: |
$40,000 - 1 year |
Eligibility: |
RSNA Member (at any level) at
time of application.
Full-time faculty position in department of radiology, radiation oncology, or
nuclear medicine.
Certified by the American Board of Radiology (ABR) or equivalent, or on
track for certification.
See Details for addnl. Criteria. |
Links: |
Funding Opportunities Ι
Details/Application |
|
NEW
|
January 17 (LOI) |
All Faculty |
Federal |
Early Detection Etiology |
Utilizing the PLCO
Biospecimens Resource to Bridge Gaps in Cancer
Etiology and Early Detection Research
To advance research in cancer etiology and early detection biomarkers,
utilizing the biorepository resources of the
NCI-sponsored Prostate, Lung, Colorectal, and
Ovarian Cancer (PLCO) Screening Trial. Projects
that do not involve the use of PLCO biospecimens
will not be supported under this FOA.
Due Dates: |
Jan. 17 (Letter of Intent)
Applications due:
Feb. 14 (OSR) Ι Feb. 17 (Sponsor) |
Amount & Project Period: |
Budgets are not limited - 5 years |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-297 |
|
NEW
|
January 27 |
All Ranks |
Federal |
Tumor Analysis |
Proteogenomic Translational Research Centers
for Clinical Proteomic Tumor Analysis Consortium
This Funding Opportunity Announcement (FOA) is a
part of the NCI Clinical Proteomic Tumor
Analysis Consortium (CPTAC). Applications
solicited for multidisciplinary Proteogenomic
Translational Research Centers (PTRCs). PTRCs
are intended to function as an interactive group
focused on applying standardized
state-of-the-art proteomic and genomic
approaches to clinically-relevant research
projects.
Due Dates: |
Jan. 25 (OSR) Ι Jan. 27 (Sponsor) (w/letter of
intent submitted 30 days prior.) |
Amount & Project Period: |
May not exceed $910,000/yr. (Direct Costs) - 5
years |
Eligibility: |
Applications must designate at least two
PDs/PIs: one expert in proteomics and another expert in clinical trials.
An individual designated as a PD/PI on an application in response to the
PGDAC FOA,
RFA-15-023, cannot be designated as a PD/PI under this FOA. However,
an individual designated as a PD/PI on an application in response to the
PCC FOA
RFA-CA-15-021) can be designated as a PD/PI under this FOA |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-CA-15-022 |
Companion RFAs: |
RFA-CA-15-021: Proteome Characterization Centers for Clinical
Proteomic Tumor Analysis Consortium (U24)
RFA-CA-15-023: Proteogenomic Data Analysis Centers for
Clinical Proteomic Tumor Analysis Consortium (U24) |
|
NEW
|
January 29 |
Junior Faculty |
Non-federal |
Career Development |
American Gastroenterological Association
AGA-Caroline Craig Augustyn & Damian
Augustyn Award in Digestive Cancer
To support young investigators, instructors, research associates or
equivalents conducting research relevant to the
pathogenesis, prevention, diagnosis, or
treatment of digestive cancer.
Due Dates: |
Jan. 27 (OSR) Ι Jan. 29 (Sponsor) |
Amount & Project Period: |
$40,000 - 1 year |
Eligibility: |
MD, PhD or equivalent degree w/full time
faculty appointment.
Must hold NIH K series or other federal or non-federal career
development award of at least 4 years duration and w/at least
1 year left at start of this award.
MD applicants: <
7 years following completion of clinical training (GI
fellowship or its equivalent) at start date of this award.
PhD applicants: <
7 years following award of PhD at start date
of this award.
AGA membership required |
Contact: |
Linda
Nolan (x6071) |
Link: |
Guidelines |
|
NEW |
January 29 |
All Ranks |
Non-federal |
Pancreatic |
The National Pancreas Foundation
Research Grants
Supports funding of research related to
pancreatic diseases intended to advance
knowledge in pancreatic carcinoma.
|
NEW |
February 01 |
All Ranks |
Non-federal |
Sarcoma |
Sarcoma Foundation of America
Research Grants
The SFA will only accept applications that focus
on the following areas of research:
1. Omic characterization of sarcomas and
definition of novel targets.
2. Omic patterns of sensitivity and
resistance to existing agents Systemic therapy
combinations. 3. Immunotherapy.
|
NEW
|
February 03 (LOI) |
All Ranks |
Federal |
Caregiver Health |
Promoting Caregiver Health Using
Self-Management
To stimulate research in promoting caregiver health using self-management.
Informal caregivers (lay caregivers) are defined
as unpaid individuals (spouses, partners, family
members, friends, or neighbors) involved in
assisting others with activities of daily living
and/or medical tasks. This concept focuses on
informal caregivers.
Due Dates: |
Feb. 03 (Letter of Intent)
Applications: Mar. 01 (OSR) Ι Mar. 03 (Sponsor) |
Amount & Project Period: |
Budgets are not limited - 5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-NR-16-003 |
|
NEW
|
February 05 |
All Ranks |
Federal |
Survivorship |
Examination of Survivorship Care Planning
Efficacy and Impact
To stimulate research evaluating the effect of care planning on
self-management of late effects of cancer
therapy; adherence to medications, cancer
screening, and health behavior guidelines;
utilization of follow-up care; survivors' health
and psychosocial outcomes.
Due Dates: |
Standard dates Feb. 03 (OSR) Ι Feb. 05 (Sponsor) |
Amount & Project Period: |
Budgets are not limited - 5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-16-012 See Companion R21 FOA:
PA-16-011 |
|
NCI is a participating institute
NEW
|
February 05 |
All Ranks |
Federal |
Multisensory Processing |
Research on the Mechanisms and/or Behavioral
Outcomes of Multisensory Processing
NCI supports multisensory research in the
context of cancer and cancer control. Topics of
interest include:
1) Studies of multisensory interactions w/taste
that might govern healthy vs. unhealthy eating,
drinking, or smoking;
2) disruption of multisensory perception by
cancer and cancer treatments;
3) potential for using multisensory interactions
to enhance health communications;
4) multisensory control of attention, as might
be relevant in complex oncology or cancer care
settings; and
5) circadian and sleep-dependent influences on
multisensory interactions.
NCI will support
both human and animal model studies.
Due Dates: |
Standard dates Feb. 03 (OSR) Ι Feb. 05 (Sponsor) |
Amount & Project Period: |
Application budgets are not limited - 5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-15-347 |
|
NEW
|
February 05 |
All Ranks |
Federal |
Chronic Illness |
Personalized Strategies to Manage Symptoms
of Chronic Illness
Interdisciplinary research to decrease symptom burden and enhance
health-related quality of life (HRQL) in persons
with chronic illness through a) increasing
knowledge of the biological mechanisms of
symptoms, and b) promoting innovative,
cost-effective, targeted interventions to
prevent, manage or ameliorate these symptoms.
|
NEW |
February 05 |
All Ranks |
Federal |
Symptom Science & Genomics |
Innovative Questions in Symptom Science and Genomics
Initiative seeks to optimize innovation, insight and cutting edge
conceptual and technological breakthroughs by catalyzing
research that emanates from the identified innovative questions
in symptom and genomic nursing science. These innovative
questions are reflective of broad domains from which more
specific novel hypotheses or problems to be solved can be
derived.
|
NEW |
February 05 |
All Ranks |
Federal |
Metabolomics |
Applying Metabolomics to Drive Biomarker Discovery in
Symptom Science
Biomarker discovery utilizing metabolomics approaches to advance the
understanding, assessment and management of symptoms
Due Dates: |
Standard dates Feb. 03 (OSR) Ι Feb. 05 (Sponsor) |
Amount & Project Period: |
Budgets are not limited - 5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-16-030 |
Companion FOA: |
PA-16-029 (R21) |
|
NEW |
February 12 (LOI) |
Established Investigators |
Non-federal |
See Below |
Cancer Research UK
Grand Challenge Awards
Seeking applications from interdisciplinary
teams with novel, exciting ways of solving one
of seven Grand Challenges:
1. Develop vaccines to prevent non-viral
cancers
2. Eradicate EBV-induced cancers from the
world
3. Discover how unusual patterns of mutation
are induced by different cancer-causing events
4. Distinguish between lethal cancers that
need treating, and non-lethal cancers that do
not
5. Find a way of mapping tumors at the
molecular and cellular level
6. Develop innovative approaches to target
cancer super-controller MYC
7. Deliver biologically active macromolecules
to any and all cells in the body
Due Dates: |
Feb. 12 (Letter of Intent)
Invited Submissions: Jul. 29 (OSR) Ι Jul. 31 (Sponsor) |
Amount & Project Period: |
£20m - 5 years |
Eligibility: |
Team must have a principal and up to 7
co-investigators; be interdisciplinary; include a patient advocate; and
must have a strong UK component w/at least 25% of grant funding
spent in the UK . |
Contact: |
Linda
Nolan (x6071) |
Links: |
Cancer Research UK Ι
Overview Ι
RFP |
|
|
February 12 |
Postdocs |
Federal |
Career Development |
AHRQ Mentored Clinical Scientist Research
Career Development Award
Provides support and protected time to individuals with a clinical
doctoral degree for an intensive, supervised
research career development experience in health
services research.
Due Dates: |
Standard dates Feb. 10 (OSR) Feb. 12 (Sponsor) |
Amount & Project Period: |
A portion of applicant salary,
of up to $90,000 annually plus associated fringe benefits; $25,000 in
direct costs per year for the following: a) related tuition and fees;
b) research expenses; c) travel to research meetings or training; d)
statistical services. |
Eligibility: |
Candidate must have received a clinical
doctoral degree from an accredited domestic or foreign institution.
Must be a citizen or a noncitizen national of the U.S. or have been
lawfully admitted for permanent residence.
See
FOA for other criteria. |
Contact: |
Linda
Nolan (x6071) |
Links: |
PA-13-039 (Expires May 24, 2016) |
|
Common Fund Initiative
NEW
|
February 15 |
See Below |
Federal |
Metabolomics |
Collaborative Activities to Promote
Metabolomics Research
Supports supplemental funding to current NIH-funded research projects for
new interactive collaborations between basic or
clinical researchers and metabolomics experts to
add a metabolomics approach to the existing
Research Strategy of the project.
Due Dates: |
Feb. 13 (OSR) Ι Feb. 15 (Sponsor) |
Amount & Project Period: |
$100,000 (Direct Costs) - Maximum of 12
months' funding;
must commence in fiscal year 2016. |
Eligibility: |
Collaborations must be
composed of at least one biomedical research investigator and at least
one investigator with documented experience in comprehensive
metabolomics analyses.
Parent awards must be funded through June 30, 2017,
exclusive of any no cost extension.
Only one application per parent award is allowed. |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-16-005 |
|
NIH Roadmap initiative
NEW
|
February 18 (LOI) |
All Ranks |
Federal |
Physical Activity Omics |
Molecular Transducers of Physical Activity
Genomics, Epigenomics, and Transcriptomics
Chemical Analysis Sites
Awards will support establishment of sites that will use appropriate
technology to conduct genomics, epigenomics, and
transcriptomics analysis of tissues collected
from human participants and animals undergoing a
physical activity intervention, contribute that
data to a public consortium database, and
participate in initial statistical analysis to
generate fingerprints of candidate molecular
transducers of physical activity.
Due Dates: |
Feb. 18 (Letter of Intent)
Applications due: Mar. 16 (OSR) Ι Mar. 18 (Sponsor) |
Amount & Project Period: |
Budgets are limited to direct costs of $50,000
year 01; $3,000,000 year 02; $4,500,000 years 03 through 05; and
$3,500,000 direct costs in year 6. |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-RM-15-010 |
Companion RFAs: |
RFA-RM-15-011, U24 - Molecular Transducers of Physical Activity
Metabolomics and Proteomics Chemical Analysis Sites
RFA-RM-15-012, U24 - Molecular Transducers of Physical Activity
Bioinformatics Center
RFA-RM-15-013, U01 - Molecular Transducers of Physical Activity
Preclinical Animal Study Sites
RFA-RM-15-014, U24 - Molecular Transducers of Physical Activity
Consortium Coordinating Center (CCC)
RFA-RM-15-015, U01 - Molecular Transducers of Physical Activity
Clinical Centers |
|